Department of Preventive Medicine, College of Korean Medicine, Daegu Haany University, Gyeongsan, Republic of Korea.
Department of Education & Research, Seoul Korean Medicine Hospital of Daejeon University, Seoul, Republic of Korea.
Medicine (Baltimore). 2024 Jul 26;103(30):e39116. doi: 10.1097/MD.0000000000039116.
The objective of this study was to explore the key elements of Korean medicine (KM) treatment for idiopathic short stature (ISS) by analyzing the strengths, weaknesses, opportunities, and threats (SWOT). This was a qualitative study of interviews with 7 KM doctors who had at least 3 years of experience in KM treatment for ISS. Based on the content, a SWOT and a cross-SWOT analysis were conducted. A SWOT of KM treatment for ISS was derived as follows: Strengths included the additional positive health promotion effects and fewer possibilities of adverse effects. Weaknesses included insufficient long-term evidence on the effect and safety and difficulty in predicting prognosis for ISS treatment in KM. Opportunities included a growing interest in height growth in general and the need for parental involvement in children height growth. Threats included the limited use of diagnostic devices and relatively high medical costs due to non-coverage by national health insurance. This study suggests that the safety and clinical effectiveness evidence of KM treatment for height growth should be guaranteed through well-designed large-scale long-term studies. Various strategies are needed to promote the use of diagnostic and evaluation devices for ISS treatment in KM clinical settings.
本研究旨在通过分析韩国医学（KM）治疗特发性身材矮小症（ISS）的优势、劣势、机会和威胁（SWOT），探讨其关键要素。这是一项对 7 名至少有 3 年 KM 治疗 ISS 经验的 KM 医生进行访谈的定性研究。根据内容进行了 SWOT 和交叉 SWOT 分析。KM 治疗 ISS 的 SWOT 如下：优势包括额外的积极健康促进作用和较少发生不良反应的可能性。劣势包括关于效果和安全性的长期证据不足，以及 KM 治疗 ISS 预后预测困难。机会包括人们对身高增长的兴趣日益增加，以及父母参与孩子身高增长的需求。威胁包括由于国家健康保险不涵盖，诊断设备的使用受限，以及相对较高的医疗费用。本研究表明，应通过精心设计的大规模长期研究来保证 KM 治疗身高增长的安全性和临床疗效证据。需要采取各种策略来促进 KM 临床环境中 ISS 治疗的诊断和评估设备的使用。
